Seagen
SEAGEN is Biotechnology company with headquarters is in Washington, USA.
Pfizer acquired Seagen for 43 billion USD in 2023. Seagen manufactures Cancer drugs.
As on 2022, SEAGEN has 3,256 employees.
SEAGEN annual revenue generated for period ending Dec-2022 was 1,962 million USD.
SEAGEN annual net loss generated for period ending Dec-2022 was -610 (Loss) million USD.